Neuromuscular
Clinical Research
If you think you may qualify for one of these studies, please contact Neurology Research Partners at (303) 724-4644 or NeurologyResearchPartners@CUAnschutz.edu
| COMIRB # | Title (Please click on the title to see approved advertisement) | Principal Investigator | Eligibility and Information | Advertisement |
|---|---|---|---|---|
| 18-1768 | Genomic Translation for Amyotrophic Lateral Sclerosis Care (GTAC) | Laura Foster, MD | Clinical Trials | N/A |
| 18-2341 | A Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults with Generalized Myasthenia Gravis | Dianna Quan, MD | Clinical Trials | N/A |
| 18-2537 | Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others (INC-6601) | Vera Fridman, MD | Clinical Trials | N/A |
| 19-0772 | A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Ravulizumab in Complement-Inhibitor-Naïve Adult Patients with Generalized Myasthenia Gravis | Stacy Dixon, MD | Clinical Trials | N/A |
| 08-0623 | Transthyretin-Associated Amyloidoses Outcomes Survey (THAOS): A Global, Multi-Center, Longitudinal, Observational Survey of Patients with Documented Transthyretin (TTR) Mutations or Wild-Type TTR Amyloidosis | Dianna Quan, MD | Clinical Trials | N/A |
| 17-1132 | Using Next Generation Sequencing to Unravel the Pathogenesis of Sporadic Inclusion Body Myositis (IBM) – The International IBM Consortium Genetic Study | Matthew Wicklund, MD | N/A | N/A |